drugset / Trial / NCT04035707

Serum Tryptase Concentration During General Anaesthesia With Rocuronium

NCT04035707

Completed 126 enrolled Medical University of Bialystok
Non-randomizedParallel-groupSingle-blindTreatment

Summary

Rocuronium is a aminosteroid structured, non-depolarizing neuromuscular blocking agents (NMB). Epidemiological data presents that the frequency of hypersensitivity reactions caused by rocuronium have been increased. Determinations of serum tryptase concentrations are interdisciplinary recommended in diagnosis of its adverse reactions. No studies have been performed to explain specific role of rocuronium doses on serum tryptase values. The aim of this study was to investigate the potential effect of rocuronium on serum tryptase concentrations.

Timeline

Start
2009-06-25
Primary completion
2010-06-25
Completion
2014-05-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Rocuronium Other / unclassified